Kamada
KMDA • NASDAQ
Kamada is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Amir London, with a market cap of $490.9M.
Market Cap$490.9M
Employees378.0
CEOAmir London
CountryIsrael
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Kamada FAQ
Common questions about Kamada
Kamada is scheduled to report earnings for Q1 2026 on May 13, 2026. Analysts estimate revenue of $105.3M.
Kamada has approximately 378 employees.